Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Thomas F Feiner

Thomas F Feiner

Institute for EEG-Neurofeedback, Germany

Title: Clinical EEG-neuroimaging, EEG-biomarkers and neurofeedback

Biography

Biography: Thomas F Feiner

Abstract

It is well known that pathologies affect certain brain regions with either increased or decreased brain wave activity. For example, typical depression has an increased activation in the insula according to fMRI studies. A technology called QEEG has shown over the years that EEG can also be used for neuroimaging, showing topographically regions in the brain with either excessive or insufficient activity. But many times those changes in brain wave activity are very subtle and so invisible for the naked eye. Another problem is how to quantify activity as normal on the one hand and deviant at the other hand. With the use of databases it is possible to quantify those subtle changes and show significantly altered brain activity which are correlated to symptoms. Newer EEG-Neuroimaging Techniques like sLORETA can look into deeper brain structures like Brodman Areas and parts of the limbic system. The technology is called standardized low-resolution brain electromagnetic tomography (sLORETA) which incorporates a mathematical inverse solution of surface EEG data to provide cortical source localization, and generating three-dimensional images, similar to those produced by fMRI data. The deviations shown in Z-Scores can have correlations in structural, emotional and
neurocognitive changes in the brain, which give new understanding in the underlying mechanisms of psychiatric disorders following a brain damage. But where there is a problem we can also see the solution. Working with those EEG-Biomarkers, can also guide the Neurofeedback clinician in the treatment by altering these patterns via operant conditioning targetting regions that show the most deviation correlated with the symptoms of the client.